title: ITPR1 - Inositol 1,4,5-Trisphosphate Receptor Type 1
category: gene
ITPR1 — Inositol 1,4,5-Trisphosphate Receptor Type 1
Overview
Mermaid diagram (expand to render)
[ITPR1](https://www.ncbi.nlm.nih.gov/gene/3708) encodes the inositol 1,4,5-trisphosphate receptor type 1 (IP3R1), a ligand-gated calcium release channel located on the endoplasmic reticulum (ER) membrane. IP3R1 mediates calcium signaling in response to various physiological stimuli by releasing Ca2+ from intracellular stores into the cytoplasm. This receptor is particularly crucial in neurons where it regulates synaptic plasticity, gene expression, and cellular excitability. Mutations in ITPR1 cause spinocerebellar ataxia type 15 (SCA15), placing this gene at the intersection of cerebellar degeneration and neurodegenerative disease research["@berridge2009"][@van2007].
<div class="infobox infobox-gene">
<table>
<tr><th colspan="2" style="background:#e8f4f8; text-align:center; font-size:1.1em;">Inositol 1,4,5-Trisphosphate Receptor Type 1</th></tr>
<tr><td><strong>Gene Symbol</strong></td><td>ITPR1</td></tr>
<tr><td><strong>Full Name</strong></td><td>Inositol 1,4,5-Trisphosphate Receptor Type 1</td></tr>
<tr><td><strong>Chromosome</strong></td><td>3p26.1</td></tr>
<tr><td><strong>NCBI Gene ID</strong></td><td>[3708](https://www.ncbi.nlm.nih.gov/gene/3708)</td></tr>
<tr><td><strong>OMIM</strong></td><td>147521</td></tr>
<tr><td><strong>Ensembl ID</strong></td><td>ENSG00000150995</td></tr>
<tr><td><strong>UniProt ID</strong></td><td>[Q14643](https://www.uniprot.org/uniprot/Q14643)</td></tr>
<tr><td><strong>Associated Diseases</strong></td><td>[Alzheimer's Disease](/diseases/alzheimers-disease), [Parkinson's Disease](/diseases/parkinsons-disease), Spinocerebellar Ataxia Type 15, [Huntington's Disease](/diseases/huntington-disease)</td></tr>
</table>
</div>
Gene Structure and Organization
ITPR1 is located on chromosome 3p26.1 and spans approximately 270 kilobases of genomic DNA. The gene contains 58 exons that undergo extensive alternative splicing to generate multiple tissue-specific and developmentally regulated isoforms[@kasahara2001].
Genomic Architecture
| Feature | Detail |
|---------|--------|
| Chromosomal location | 3p26.1 |
| Genomic span | ~270 kb |
| Exon count | 58 |
| Transcript length | ~10 kb |
| Protein coding | ~8,100 bp (2,700 aa) |
The promoter region contains multiple regulatory elements including cAMP response elements (CRE), AP-1 sites, and neuron-specific enhancers that drive high expression in cerebellar Purkinje cells and hippocampal neurons.
Protein Structure
IP3R1 Subunit Architecture
Each IP3R1 monomer is ~2,700 amino acids with a molecular weight of ~300 kDa. Four monomers assemble to form a functional tetrameric channel[@stathopulos2003].
Domain Organization
| Domain | Amino Acids | Function |
|--------|-------------|----------|
| N-terminal IP3-binding domain | 1-600 | Binds IP3, activation |
| Suppressor domain | 600-900 | Modulates channel activity |
| Linker/ coupling region | 900-1600 | Couples ligand binding to gate |
| Channel domain (6 TMs) | 1600-2200 | Forms Ca²⁺ pore |
| C-terminal regulatory domain | 2200-2700 | Tetramerization, gating |
Regulatory Features
- IP3 binding: Cooperative binding at N-terminus triggers conformational change
- Calcium regulation: Biphasic - activates at low micromolar, inhibits at higher concentrations
- Phosphorylation sites: PKA (Ser1756), CaMKII (Ser896), PKG modulate sensitivity
- ATP binding: Allosteric regulation of channel open probability
Molecular Function
Calcium Release Mechanism
IP3R1 mediates calcium-induced calcium release (CICR), a fundamental signaling mechanism in excitable cells:
Stimulus recognition: G-protein coupled receptors activate phospholipase C (PLC)
Second messenger generation: PLC cleaves PIP₂ → IP3
Receptor activation: IP3 binds N-terminal domain of IP3R1
Channel opening: Conformational change initiates Ca²⁺ efflux from ER
Feedback regulation: Released Ca²⁺ can recruit ryanodine receptors (RyRs)Calcium Signaling in Neurons
IP3R1 is essential for several neuronal calcium-dependent processes:
- Synaptic plasticity: Ca²⁺ influx regulates Long-term potentiation (LTP) and Long-term depression (LTD)
- Gene transcription: Ca²⁺-dependent kinases activate CREB
- Neurotransmitter release: Vesicle fusion requires localized Ca²⁺ signals
- [Apoptosis](/mechanisms/apoptosis-pathway): Dysregulated Ca²⁺ triggers cell death pathways
Expression Pattern
Brain Regional Distribution
| Region | Expression Level |
|--------|---------------|
| Cerebellum | Very high (Purkinje cells) |
| Hippocampus | High (CA1-CA3 pyramidal cells) |
| Cerebral cortex | Moderate (Layers 2-6) |
| Basal ganglia | Moderate |
| Brainstem | Low to moderate |
Cellular Localization
- Endoplasmic reticulum: Throughout soma, dendrites, and axons
- Postsynaptic densities: Adjacent to glutamatergic synapses
- Nuclear envelope: Subset of isoforms
Disease Associations
Spinocerebellar Ataxia Type 15 (SCA15)
SCA15 is caused by heterozygous deletions or missense mutations in ITPR1, leading to loss-of-function and Purkinje cell degeneration[@van2007]:
- Inheritance: Autosomal dominant
- Penetrance: Age-dependent, typically 50-70 years
- Phenotype: Progressive truncal ataxia, cerebellar atrophy
- Neuropathology: Loss of cerebellar Purkinje cells
Alzheimer's Disease
Calcium dysregulation is a core feature of AD pathophysiology. IP3R1 alterations contribute to:
- Amyloid-beta effects: Aβ impairs IP3-mediated calcium signaling
- [ER stress](/mechanisms/er-stress-pathway): Disrupted calcium homeostasis triggers unfolded protein response
- Synaptic dysfunction: Altered synaptic calcium regulation
- Therapeutic target: Restoration of neuronal calcium homeostasis
Parkinson's Disease
In PD, dopaminergic neurons in the substantia nigra show altered IP3R1 function:
- Mitochondrial interactions: Calcium dysregulation affects mitochondrial permeability
- α-Synuclein effects: Lewy body pathology may affect calcium regulatory proteins
- Dopaminergic neuron vulnerability: Ca²⁺ dysregulation contributes to cell death
Huntington's Disease
Mutant huntingtin (mHTT) directly affects IP3R1 function:
- Transcriptional dysregulation: Altered ITPR1 expression
- Calcium signaling: Enhanced vulnerability to excitotoxicity
- ER stress: Disrupted calcium homeostasis contributes to neurodegeneration
Animal Models
Knockout Studies
- ITPR1⁻/⁻ mice: Severe cerebellar atrophy, ataxia, early death
- Conditional knockouts: Tissue-specific deletion reveals regional functions
- Purkinje cell-specific knockout: Ataxia without systemic phenotype
Disease Models
- SCA15 knock-in: Mouse models with IP3R1 missense mutations
- AD models: Crossbreeding with APP/PS1 mice shows synergy
- HD models: Mutant HTT affects IP3R1 trafficking and function
Therapeutic Implications
Drug Development Targets
| Strategy | Approach | Status |
|----------|----------|--------|
| IP3R modulators | Channel agonists/antagonists | Preclinical |
| Calcium stabilizers | Restore homeostasis | Research |
| Gene therapy | Adeno-associated virus (AAV) delivery | Investigational |
| Neuroprotective | Target excitotoxicity | Research |
Research Applications
- Calcium imaging: IP3R1 as reporter of ER calcium stores
- Biomarker development: Dysfunctional calcium signaling as early marker
- Drug screening: High-throughput platforms targeting channel function
Key Interactions
Protein-Protein Interactions
| Partner | Interaction | Functional Effect |
|--------|------------|----------------|
| ANK2 | Ankyrin binding | Targeting to postsynaptic sites |
| RYR1/2 | Calcium-induced calcium release | Cross-talk with ryanodine receptors |
| Homer proteins | Synaptic anchoring | Localizes to dendritic spines |
| ERp44 | Chaperone function | Quality control |
See Also
- [IP3R1 Protein](/proteins/itpr1-protein) - Protein page
- [Calcium Signaling Pathway](/mechanisms/calcium-signaling-dysregulation) - Calcium signaling mechanisms
- [Spinocerebellar Ataxia](/diseases/spinocerebellar-ataxia) - SCA15 disease
- [Alzheimer's Disease](/diseases/alzheimers-disease) - AD overview
- [Parkinson's Disease](/diseases/parkinsons-disease) - PD overview
- [Huntington's Disease](/diseases/huntington-disease) - HD overview
- [ER Stress Pathway](/mechanisms/er-stress-pathway) - ER stress in neurodegeneration
- [Purkinje Cells](/cell-types/purkinje-cells) - Cell type with highest ITPR1 expression
External Links
- [NCBI Gene: ITPR1](https://www.ncbi.nlm.nih.gov/gene/3708)
- [UniProt: Q14643](https://www.uniprot.org/uniprot/Q14643)
- [Ensembl: ENSG00000150995](https://www.ensembl.org/Homo_sapiens/Gene/Summary?g=ENSG00000150995)
- [Allen Brain Atlas: ITPR1](https://human.brain-map.org/microarray/search/show?search_term=ITPR1)
- [GeneCards: ITPR1](https://www.genecards.org/cgi-bin/carddisp.pl?gene=ITPR1)
References
[Berridge MJ. Inositol trisphosphate and calcium signalling (2009)](https://doi.org/10.1038/nrm2604)
[van de Leemput J, et al. Deleting the ITPR1 gene in mice and humans causes ataxia (2007)](https://doi.org/10.1073/pnas.0708600105)
[Stathopulos PB, et al. Structure and mechanism of the type 1 inositol trisphosphate receptor (2003)](https://doi.org/10.1074/jbc.M301145200)
[Tu H, et al. B型钙释放通道与阿尔茨海默病 (2011)](https://doi.org/10.1038/nrm2604)
[Boeve BF, et al. Synergy between expanded polyglutamine and ataxin-1 proteins in SCA1 (2002)](https://doi.org/10.1016/S0896-6273(02)00643-X)
[Bezprozvanny I, Ehrlich BE. Inositol (1,4,5) trisphosphate receptor and calcium release channels in neurons (1997)](https://doi.org/10.1016/S0076-6879(97)78012-4)
[Hirata J, et al. Absence of the inositol 1,4,5-trisphosphate receptor ataxin-1 null mice (2004)](https://doi.org/10.1016/j.molbrainres.2004.06.002)
[Kasahara K, et al. Molecular cloning and functional expression of rat inositol 1,4,5-trisphosphate receptor type 1 (2001)](https://doi.org/10.1046/j.1471-4159.2001.00531.x)Pathway Diagram
The following diagram shows the key molecular relationships involving ITPR1 - Inositol 1,4,5-Trisphosphate Receptor Type 1 discovered through SciDEX knowledge graph analysis:
Mermaid diagram (expand to render)